Literature DB >> 7839831

Hereditary cerebral hemorrhage with amyloidosis (Dutch): a model for congophilic plaque formation without neurofibrillary pathology.

M L Maat-Schieman1, C M Radder, S G van Duinen, J Haan, R A Roos.   

Abstract

Plaque-like lesions and amyloid angiopathy were investigated in the frontal cerebral cortex of four patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) (HCHWA-D), using immunohistochemical [antibodies to beta amyloid protein (A beta), beta protein precursor (beta PP), synaptophysin, ubiquitin (UBQ), cathepsin D, paired helical filaments (PHF) and glial fibrillary acidic protein (GFAP)], enzymehistochemical (acid phosphatase) and silver [methenamine silver (MS) and Palmgren] staining methods. Whereas A beta- and MS-positive diffuse plaques were found in all patients, only the three older patients showed neuritic or congophilic plaques, which were acid phosphatase and cathepsin D positive and contained beta PP-, synaptophysin- and UBQ-positive, but PHF-negative neurites. These plaques were surrounded by reactive astrocytes. Similar immuno- and enzymereactivity was found around congophilic blood vessels. Thus, apart from neuronal degeneration in a subset of plaque-like lesions and around blood vessels, this study shows an age-related morphology of the plaques in HCHWA-D, corresponding to that in Down's syndrome (DS), with the difference that neurofibrillary (NF) pathology is absent in HCHWA-D in contrast to DS. HCHWA-D may be considered as a model for congophilic plaque formation not associated with NF pathology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7839831     DOI: 10.1007/bf00310382

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  48 in total

1.  Amyloid beta-protein precursor accumulates in dystrophic neurites of senile plaques in Alzheimer-type dementia.

Authors:  M Shoji; S Hirai; H Yamaguchi; Y Harigaya; T Kawarabayashi
Journal:  Brain Res       Date:  1990-03-26       Impact factor: 3.252

2.  Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain.

Authors:  H Yamaguchi; C Haga; S Hirai; Y Nakazato; K Kosaka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease.

Authors:  E Cochran; B Bacci; Y Chen; A Patton; P Gambetti; L Autilio-Gambetti
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

4.  The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects.

Authors:  L I Benowitz; W Rodriguez; P Paskevich; E J Mufson; D Schenk; R L Neve
Journal:  Exp Neurol       Date:  1989-12       Impact factor: 5.330

5.  Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques.

Authors:  C Joachim; D Games; J Morris; P Ward; D Frenkel; D Selkoe
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

6.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

Authors:  F Tagliavini; G Giaccone; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

7.  Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease.

Authors:  S G van Duinen; E M Castaño; F Prelli; G T Bots; W Luyendijk; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Ubiquitinated neurites are associated with preamyloid and cerebral amyloid beta deposits in patients with hereditary cerebral hemorrhage with amyloidosis Dutch type.

Authors:  F Tagliavini; G Giaccone; O Bugiani; B Frangione
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

Authors:  M Shoji; T E Golde; J Ghiso; T T Cheung; S Estus; L M Shaffer; X D Cai; D M McKay; R Tintner; B Frangione
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

10.  Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.

Authors:  B T Hyman; R E Tanzi; K Marzloff; R Barbour; D Schenk
Journal:  J Neuropathol Exp Neurol       Date:  1992-01       Impact factor: 3.685

View more
  11 in total

1.  β-Amyloid carrying the Dutch mutation has diverse effects on calpain-mediated toxicity in hippocampal neurons.

Authors:  Alexandra M Nicholson; Lindsey A Wold; Dominic M Walsh; Adriana Ferreira
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

2.  Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers.

Authors:  Aaron P Schultz; Reina W Kloet; Hamid R Sohrabi; Louise van der Weerd; Sanneke van Rooden; Marieke J H Wermer; Laure Grand Moursel; Maqsood Yaqub; Bart N M van Berckel; Pratishtha Chatterjee; Samantha L Gardener; Kevin Taddei; Anne M Fagan; Tammie L Benzinger; John C Morris; Reisa Sperling; Keith Johnson; Randall J Bateman; M Edip Gurol; Mark A van Buchem; Ralph Martins; Jasmeer P Chhatwal; Steven M Greenberg
Journal:  Ann Neurol       Date:  2019-08-12       Impact factor: 10.422

3.  Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study.

Authors:  Anna M van Opstal; Sanneke van Rooden; Thijs van Harten; Eidrees Ghariq; Gerda Labadie; Panagiotis Fotiadis; M Edip Gurol; Gisela M Terwindt; Marieke J H Wermer; Mark A van Buchem; Steven M Greenberg; Jeroen van der Grond
Journal:  Lancet Neurol       Date:  2016-12-16       Impact factor: 44.182

4.  Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types.

Authors:  A K Sian; E R Frears; O M El-Agnaf; B P Patel; M F Manca; G Siligardi; R Hussain; B M Austen
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

5.  Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.

Authors:  D M Mann; T Iwatsubo; Y Ihara; N J Cairns; P L Lantos; N Bogdanovic; L Lannfelt; B Winblad; M L Maat-Schieman; M N Rossor
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy.

Authors:  Marcel M Verbeek; Berry P H Kremer; Marcel Olde Rikkert; Peter H M F Van Domburg; Maureen E Skehan; Steven M Greenberg
Journal:  Ann Neurol       Date:  2009-08       Impact factor: 10.422

7.  Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein.

Authors:  J Davis; W E Van Nostrand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

8.  Decreased Basal Ganglia Volume in Cerebral Amyloid Angiopathy.

Authors:  Panagiotis Fotiadis; Marco Pasi; Andreas Charidimou; Andrew D Warren; Kristin M Schwab; Jonathan Rosand; Jeroen van der Grond; Mark A van Buchem; Anand Viswanathan; M Edip Gurol; Steven M Greenberg
Journal:  J Stroke       Date:  2021-05-31       Impact factor: 6.967

9.  Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal.

Authors:  Stuart J McCarter; Timothy G Lesnick; Val Lowe; Michelle M Mielke; Eleni Constantopoulos; Alejandro A Rabinstein; Scott A Przybelski; Hugo Botha; David T Jones; Vijay K Ramanan; Clifford R Jack; Ronald C Petersen; David Knopman; Bradley F Boeve; Melissa E Murray; Dennis W Dickson; Prashanthi Vemuri; Kejal Kantarci; R Ross Reichard; Jonathan Graff-Radford
Journal:  Neurology       Date:  2021-09-09       Impact factor: 9.910

10.  MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy.

Authors:  Paula Marazuela; Montse Solé; Anna Bonaterra-Pastra; Jesús Pizarro; Jessica Camacho; Elena Martínez-Sáez; H Bea Kuiperij; Marcel M Verbeek; Anna M de Kort; Floris H B M Schreuder; Catharina J M Klijn; Laura Castillo-Ribelles; Olalla Pancorbo; David Rodríguez-Luna; Francesc Pujadas; Pilar Delgado; Mar Hernández-Guillamon
Journal:  Acta Neuropathol Commun       Date:  2021-09-16       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.